Luke JJ, Long GV, Robert C, Carlino MS, et al. Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non-small cell lung cancer, and renal cell carcinoma. Eur J Cancer 2024;207:114146.
PMID: 38838446